Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report of the
study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT02576548” into the search box and
click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5760C00001” into the search box, and click “Find a Study”.
Full study title: A Phase 1/ 2 Multicenter, Open-label, Dose-escalation, and Dose-expansion
Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity, and Antitumor Activity of
MEDI4276 in Subjects with Select HER2 expressing Advanced Solid Tumors
National Clinical Trials number: NCT02576548
AstraZeneca Protocol Number: D5760C00001
MedImmune Ltd., an AstraZeneca company, sponsored this study and has its headquarters in
Mölndal, Sweden.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting patients for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO
13
Version 1.0 2020_04_07